ALDX - Aldeyra Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income-38,893.245-22,340.589-18,699.45-12,090.287
Operating Activities, Cash Flows Provided By or Used In
Depreciation71.00337.84935.79218.778
Adjustments To Net Income3,907.3122,844.0863,025.8592,187.102
Changes In Accounts Receivables----
Changes In Liabilities2,049.582725.522-575.719509.866
Changes In Inventories----
Changes In Other Operating Activities2,948.895-510.0711,038.69226.959
Total Cash Flow From Operating Activities-29,857.131-19,222.862-15,147.512-9,311.753
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures-262.966-24.759-11.81-86.119
Investments-23,072.61-10,173.083-213.424-12,950.137
Other Cash flows from Investing Activities----
Total Cash Flows From Investing Activities-23,335.576-10,197.842-225.234-13,036.256
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid----
Sale Purchase of Stock----
Net Borrowings-1,395.833-1,395.833-1,395.833-1,395.833
Other Cash Flows from Financing Activities--165.93-165.93-36.236
Total Cash Flows From Financing Activities80,526.84237,428.9812,738.94128,469.571
Effect Of Exchange Rate Changes----
Change In Cash and Cash Equivalents27,334.1358,008.276-2,633.8056,121.562